Eugster EA, Rubin SD, Reiter EO,et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003;143:60–66.
84.
Speiser PW. Congenital adrenal hyperplasia. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. 2nd ed. Philadelphia, PA: JB Lippincott, 1995:686–695.
85.
White PC, Speiser PW. Congenital adrenal hyperplasia due to 21hydroxylase deficiency. Endocr Rev 2000;21:245–291.
86.
Engster EA, Dimeglio LA, Wright JC, et al. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 2001;138:3–5.
87.
Lajic S, Wedell A, Bui T, et al. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872–3880.
88.
New MI, Carlson A, Obeid J, et al. Extensive personal experience: prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001;86:5651–5657.
89.
Fern´andez-Balsells MM, Muthusamy K, Smushkin G, et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia due to 21 hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 2010;73:436–444.
90.
Futterweit W. Pathophysiology of polycystic ovarian syndrome. In: Redmond GP, ed. Androgenic disorders. New York: Raven Press, 1995:77–166.
91.
Rebar RW. Disorders of menstruation, ovulation, and sexual response. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. 2nd ed. Philadelphia, PA: Lippincott, 1995:880– 899.
92.
The Rotterdam ESHRE/ASRM-Sponsored PCOS Concensus Workshop Group. Revised 2003 concensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
93.
Lewy VD, Danadian K, Witchel SF, et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2001;138:38–44.
94.
Lobo RA, Goebelsmann U. Adult manifestation of congenital hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol 1980;138:720– 726.
95.
Chrousos GP, Loriaux DL, Mann DL, et al. Late-onset 21hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 1982;96:143–148.
96.